214 related articles for article (PubMed ID: 12748169)
1. Tumor necrosis factor-induced nuclear factor kappaB activation is impaired in focal adhesion kinase-deficient fibroblasts.
Funakoshi-Tago M; Sonoda Y; Tanaka S; Hashimoto K; Tago K; Tominaga S; Kasahara T
J Biol Chem; 2003 Aug; 278(31):29359-65. PubMed ID: 12748169
[TBL] [Abstract][Full Text] [Related]
2. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
3. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
4. The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF.
Devin A; Lin Y; Yamaoka S; Li Z; Karin M; Liu Zg
Mol Cell Biol; 2001 Jun; 21(12):3986-94. PubMed ID: 11359906
[TBL] [Abstract][Full Text] [Related]
5. Focal Adhesion Kinase Activity and Localization is Critical for TNF-α-Induced Nuclear Factor-κB Activation.
Murphy JM; Jeong K; Cioffi DL; Campbell PM; Jo H; Ahn EE; Lim SS
Inflammation; 2021 Jun; 44(3):1130-1144. PubMed ID: 33527321
[TBL] [Abstract][Full Text] [Related]
6. The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2.
Lee TH; Shank J; Cusson N; Kelliher MA
J Biol Chem; 2004 Aug; 279(32):33185-91. PubMed ID: 15175328
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
8. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction.
Schwandner R; Yamaguchi K; Cao Z
J Exp Med; 2000 Apr; 191(7):1233-40. PubMed ID: 10748240
[TBL] [Abstract][Full Text] [Related]
9. CSN3 interacts with IKKgamma and inhibits TNF- but not IL-1-induced NF-kappaB activation.
Hong X; Xu L; Li X; Zhai Z; Shu H
FEBS Lett; 2001 Jun; 499(1-2):133-6. PubMed ID: 11418127
[TBL] [Abstract][Full Text] [Related]
10. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
Lin Y; Devin A; Cook A; Keane MM; Kelliher M; Lipkowitz S; Liu ZG
Mol Cell Biol; 2000 Sep; 20(18):6638-45. PubMed ID: 10958661
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase.
Pantano C; Shrivastava P; McElhinney B; Janssen-Heininger Y
J Biol Chem; 2003 Nov; 278(45):44091-6. PubMed ID: 12939259
[TBL] [Abstract][Full Text] [Related]
12. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.
Huang D; Khoe M; Befekadu M; Chung S; Takata Y; Ilic D; Bryer-Ash M
Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1339-52. PubMed ID: 17135301
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression.
Schlaepfer DD; Hou S; Lim ST; Tomar A; Yu H; Lim Y; Hanson DA; Uryu SA; Molina J; Mitra SK
J Biol Chem; 2007 Jun; 282(24):17450-9. PubMed ID: 17438336
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts.
Kida Y; Kobayashi M; Suzuki T; Takeshita A; Okamatsu Y; Hanazawa S; Yasui T; Hasegawa K
Cytokine; 2005 Feb; 29(4):159-68. PubMed ID: 15652448
[TBL] [Abstract][Full Text] [Related]
15. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor alpha- and interleukin-1beta-induced IKK/NF-kappaB and JNK/AP-1 activation.
Fan Y; Yu Y; Shi Y; Sun W; Xie M; Ge N; Mao R; Chang A; Xu G; Schneider MD; Zhang H; Fu S; Qin J; Yang J
J Biol Chem; 2010 Feb; 285(8):5347-60. PubMed ID: 20038579
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation.
Lin Y; Choksi S; Shen HM; Yang QF; Hur GM; Kim YS; Tran JH; Nedospasov SA; Liu ZG
J Biol Chem; 2004 Mar; 279(11):10822-8. PubMed ID: 14701813
[TBL] [Abstract][Full Text] [Related]
17. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
[TBL] [Abstract][Full Text] [Related]
18. Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.
Lewis J; Devin A; Miller A; Lin Y; Rodriguez Y; Neckers L; Liu ZG
J Biol Chem; 2000 Apr; 275(14):10519-26. PubMed ID: 10744744
[TBL] [Abstract][Full Text] [Related]
19. The essential role of MEKK3 in TNF-induced NF-kappaB activation.
Yang J; Lin Y; Guo Z; Cheng J; Huang J; Deng L; Liao W; Chen Z; Liu Z; Su B
Nat Immunol; 2001 Jul; 2(7):620-4. PubMed ID: 11429546
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
